4//SEC Filing
KIES PETER 4
Accession 0001055726-25-000029
CIK 0001055726other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:08 PM ET
Size
9.7 KB
Accession
0001055726-25-000029
Insider Transaction Report
Form 4
KIES PETER
CFO
Transactions
- Exercise/Conversion
Common Stock
2025-05-15+4,771→ 32,823 total - Tax Payment
Common Stock
2025-05-15$1.95/sh−2,566$5,004→ 30,257 total - Exercise/Conversion
Restricted Stock Unit
2025-05-15−4,771→ 4,771 total→ Common Stock (4,771 underlying)
Holdings
- 375(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units is as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
- [F2]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein.
Documents
Issuer
INOVIO PHARMACEUTICALS, INC.
CIK 0001055726
Entity typeother
Related Parties
1- filerCIK 0001259780
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:08 PM ET
- Size
- 9.7 KB